3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
10
Lung Neoplasms
5
Recurrence
4
Neoplasm Metastasis
4
Lymphoma, T-Cell, Peripheral
2
Lymphoma, T-Cell
2
Lymphoma, B-Cell
2
Head and Neck Neoplasms
2
Breast Neoplasms
2
Waldenstrom Macroglobulinemia
1
Urinary Bladder Neoplasms
1
Thyroid Diseases
1
Smoking
1
Prostatic Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Ovarian Neoplasms
1
Oligodendroglioma
1
Neuralgia
1
Neoplasms
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Extranodal NK-T-Cell
1
Lymphoma
1
Leukemia
1
Laryngeal Diseases
1
Immunoblastic Lymphadenopathy
1
Hodgkin Disease
1
Gliosarcoma
1
Glioblastoma
1
Fallopian Tube Neoplasms
1
Interventions
Cisplatin
4
pembrolizumab
3
Nivolumab
3
Fluorouracil
2
Carboplatin
2
toripalimab
1
spartalizumab
1
fludarabine phosphate
1
fludarabine
1
cc-486
1
camrelizumab
1
Vorinostat
1
Valganciclovir
1
Range of Motion, Articular
1
Radiotherapy
1
Radiosurgery
1
Protons
1
Platinum
1
Methylprednisolone
1
Medicare Part B
1
Laryngoscopes
1
Gemcitabine
1
Docetaxel
1
Cyclophosphamide
1
Cetuximab
1
Bevacizumab
1
Azacitidine
1
Adrenal Cortex Hormones
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Nasopharyngeal Carcinoma
×
Vitamin B 12
×
Clear all
No trials found.